RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study (Q56765531)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Infliximab in patients with primary Sjögren's syndrome: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

S D Steinfeld

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

P Demols

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

I Salmon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R Kiss

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

T Appelboom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

2371-2375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

Notice of retraction of two articles (“Infliximab in patients with primary Sjögren’s syndrome: a pilot study” and “Infliximab in patients with primary Sjögren’s syndrome: one-year followup”).

13 November 2019

retracted by

0 references

cites work

Methods for collecting saliva

0 references

Prevalence of Sjögren's syndrome in a closed rural community

0 references

Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis.

0 references

Cytokines in autoimmunity

0 references

Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome

0 references

Sjögren's syndrome. Proposed criteria for classification

0 references

Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome

0 references

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

0 references

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

0 references

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

0 references

Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome

0 references

Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells.

0 references

Current issues in the diagnosis and treatment of Sjögren's syndrome

0 references

Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome

0 references

Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage

0 references

Labial salivary gland biopsy in Sjogren's disease

0 references

Identifiers

DOI

10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665979%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference